Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.
Moss DY, Brown CN, Shaw AM, McCann C, Lewis N, Downs M, Wurelly R, Cunningham C, Philips A, Doherty N, Gallagher S, McDaid WJ, Roe A, Coughlan AY, Cavanagh B, Ormsby C, Falcone F, McCole R, Monteith S, Rogan E, Malla SB, Emerson AJ, Mohammed-Smith L, Sharkey S, Leonard A, Gallagher PF, Banerjee A, Van Schaeybroeck S, Pandor S, Quinn B, Greer B, Elliott C, Maguire S, Ryan AE, Dunne PD, Mallon M, Craig S, Aftab O, Greaves LC, Marzullo BP, Tennant DA, Coyle V, Mills IG, Sansom O, Ní Chonghaile T, Longley DB, McDade SS, LaBonte MJ, Kerr EM.
Moss DY, et al. Among authors: elliott c.
Nat Metab. 2026 Jul 23. doi: 10.1038/s42255-026-01578-w. Online ahead of print.
Nat Metab. 2026.
PMID: 42493590